Medical NewsGerman Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Genetically derived surface antigens (vaccines). |
| Generic Name : | Hepatitis B |
| Drug description : | HB-Vax II: suspension in pre- filled syringe or vial. HB-Vax II 40: suspension in vial. HB-Vax II Paediatric: suspension in pre-filled syringe. |
| Presentation : | HB-Vax II: Hepatitis B surface antigen 10 microgram per mL adsorbed onto aluminium hydroxide. HB-Vax II 40: Hepatitis B surface antigen 40 microgram per mL adsorbed onto aluminium hydroxide. HB-Vax II Paediatric: Hepatitis B surface antigen 5 microgram per 0 .5 mL adsorbed onto aluminium hydroxide. |
| Indications : | HB-Vax II and HB-Vax II Paediatric: Active immunisation against hepatitis B virus. HB-Vax II 40: Active immunisation against hepatitis B virus in dialysis and predialysis dialysis and predialysis patients. |
| Adult Dosage : | HB-Vax II: 1 L by intramuscular injection into the deltoid muscle, repeated 1 month and 6 months later. Rapid immunisation, 1 mL by intramuscular injection, repeated 1 month, 2 months and 12 months later. HB-Vax II 40: 1 mL by intramuscular injection into the deltoid muscle, repeated 1 month and 6 months later. |
| Child Dosage : | HB-Vax II and HB-Vax II Paediatric: Under 16 years, 0.5 mL by intramuscular injection into the deltoid muscle, repeated 1 month and 6 months later. Rapid immunisation, 0 .5 mL by intramuscular injection, repeated 1 month, 2 months and 12 months later. HB-Vax II 40: 1 mL by intramuscular injection into the deltoid muscle, repeated 1 month and 6 months later. |
| Contra Indications : | Severe febrile infections. |
| Special Precautions : | Dialysed or immunocompromised patients may need further doses. Severe cardiac or respiratory dysfunction. Pregnancy, lactation. |
| Adverse Reactions : | Mild transient local soreness, erythema and induration at injection site, low grade fever, malaise, rash, nausea, dizziness. |
| Manufacturer : | Aventis Pasteur MSD |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org